These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 3573147)

  • 1. The preS1 protein of hepatitis B virus is acylated at its amino terminus with myristic acid.
    Persing DH; Varmus HE; Ganem D
    J Virol; 1987 May; 61(5):1672-7. PubMed ID: 3573147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A C-terminal PreS1 sequence is sufficient to retain hepatitis B virus L protein in 293 cells.
    Gallina A; Gazina E; Milanesi G
    Virology; 1995 Oct; 213(1):57-69. PubMed ID: 7483279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping of the hepatitis B virus attachment site by use of infection-inhibiting preS1 lipopeptides and tupaia hepatocytes.
    Glebe D; Urban S; Knoop EV; Cag N; Krass P; Grün S; Bulavaite A; Sasnauskas K; Gerlich WH
    Gastroenterology; 2005 Jul; 129(1):234-45. PubMed ID: 16012950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specificity of fatty acid acylation of cellular proteins.
    Olson EN; Towler DA; Glaser L
    J Biol Chem; 1985 Mar; 260(6):3784-90. PubMed ID: 3972848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. African swine fever virus fatty acid acylated proteins.
    Aguado B; Viñuela E; Alcamí A
    Virology; 1991 Dec; 185(2):942-5. PubMed ID: 1962463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myristylation is involved in intracellular retention of hepatitis B virus envelope proteins.
    Prange R; Clemen A; Streeck RE
    J Virol; 1991 Jul; 65(7):3919-23. PubMed ID: 2041101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myristic acid is incorporated into the two acylatable domains of the functional glycoprotein CD9 in ester, but not in amide bonds.
    Seehafer JG; Slupsky JR; Tang SC; Masellis-Smith A; Shaw AR
    Biochim Biophys Acta; 1990 Jun; 1039(2):218-26. PubMed ID: 2194573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applications of human hepatitis B virus preS domain in bio- and nanotechnology.
    Toita R; Kawano T; Kang JH; Murata M
    World J Gastroenterol; 2015 Jun; 21(24):7400-11. PubMed ID: 26139986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Properties of modified hepatitis B virus surface antigen particles carrying preS epitopes.
    Prange R; Werr M; Birkner M; Hilfrich R; Streeck RE
    J Gen Virol; 1995 Sep; 76 ( Pt 9)():2131-40. PubMed ID: 7561750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the preS1 RNA sequence on the efficiency of the hepatitis B virus preS2 and S protein translation.
    Masuda M; Yuasa T; Yoshikura H
    Virology; 1990 Jan; 174(1):320-4. PubMed ID: 2294645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-terminal myristoylation-dependent masking of neutralizing epitopes in the preS1 attachment site of hepatitis B virus.
    Bremer CM; Sominskaya I; Skrastina D; Pumpens P; El Wahed AA; Beutling U; Frank R; Fritz HJ; Hunsmann G; Gerlich WH; Glebe D
    J Hepatol; 2011 Jul; 55(1):29-37. PubMed ID: 21145866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A carboxy-terminal portion of the preS1 domain of hepatitis B virus (HBV) occasioned retention in endoplasmic reticulum of HBV envelope proteins expressed by recombinant vaccinia viruses.
    Nĕmecková S; Kunke D; Press M; Nĕmecek V; Kutinová L
    Virology; 1994 Aug; 202(2):1024-7. PubMed ID: 8030203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel N-terminal amino acid sequence required for retention of a hepatitis B virus glycoprotein in the endoplasmic reticulum.
    Kuroki K; Russnak R; Ganem D
    Mol Cell Biol; 1989 Oct; 9(10):4459-66. PubMed ID: 2586518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discrimination of hepatitis B virus (HBV) subtypes using monoclonal antibodies to the PreS1 and PreS2 domains of the viral envelope.
    Mimms LT; Floreani M; Tyner J; Whitters E; Rosenlof R; Wray L; Goetze A; Sarin V; Eble K
    Virology; 1990 Jun; 176(2):604-19. PubMed ID: 1693248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and characterization of chimeric hepatitis B surface antigen particles carrying preS epitopes.
    Hui J; Li G; Kong Y; Wang Y
    J Biotechnol; 1999 Jun; 72(1-2):49-59. PubMed ID: 10406098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B defective virus with rearrangements in the preS gene during chronic HBV infection.
    Gerken G; Kremsdorf D; Capel F; Petit MA; Dauguet C; Manns MP; Meyer zum Büschenfelde KH; Brechot C
    Virology; 1991 Aug; 183(2):555-65. PubMed ID: 1853561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Posttranslational acylation of the transferrin receptor in LSTRA cells with myristate, palmitate and stearate: evidence for distinct acyltransferases.
    Nadler MJ; Hu XE; Cassady JM; Geahlen RL
    Biochim Biophys Acta; 1994 Jun; 1213(1):100-6. PubMed ID: 8011671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion of the myristylation signal allows high-level production of the hepatitis B virus large surface glycoprotein preS1 with vaccinia virus recombinants.
    Pfleiderer M; Falkner FG; Dorner F
    Gene; 1996 Oct; 176(1-2):131-7. PubMed ID: 8918244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-terminal myristylation of HBV preS1 domain enhances receptor recognition.
    De Falco S; Ruvo M; Verdoliva A; Scarallo A; Raimondo D; Raucci A; Fassina G
    J Pept Res; 2001 May; 57(5):390-400. PubMed ID: 11350599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of secretion of hepatitis B surface antigen by a related presurface polypeptide.
    Persing DH; Varmus HE; Ganem D
    Science; 1986 Dec; 234(4782):1388-91. PubMed ID: 3787251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.